The Leipzig Immune ONcology (LION) Virtual Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.
Virtually or in person, you choose.
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. and virtually. Schedule at a glance here" https://www.sitcancer.org/2021...
This year's Summit4CI will explore the latest progress in cancer immunotherapy from scientific, clinical, industry and patient perspectives, through internationally recognized speakers, scientific presentations, poster sessions, a public forum and an Oxford-style debate. Plenary topics include:
- Advances in Cellular Immunotherapy
- Approaches to Making Cold Tumors Hot
- Advances in Pediatric Immunotherapy
- Debate: Who is Driving the CAR: NK Cells vs T Cells
For this year only, BioCanRx will be offering FREE registration. Register here!
Given the prominent role of RAS in so many human cancers, a comprehensive and in-depth forum for all constituents interested in RAS research is necessary to expand our knowledge of both the basic research pushing the field forward and the exciting potential for clinical application that translational science is advancing. This conference will cover a range of the topics including drug targeting, immunotherapy, metabolism, RASopathies, RAS structure and function, signaling networks, and several talks on RAS disease sites and opportunities to learn from these different diseases.
Please note that this meeting will take place as an in-person event in Lake Buena Vista and will not live-stream content for virtual participation. The meeting content will be captured and made available as an on-demand program after the meeting.
Offered as a hybrid program, attendees can participate in person or virtually to access the best in cancer immunotherapy education taught by leading experts in the field. This program provided a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.
This meeting series has a long tradition of bringing together outstanding researchers from the United States, Japan, and around the world to share their findings and present the latest advances in basic, translational, and clinical cancer research. Formal and informal interactions as well as international collaborations are fostered through this unique forum.
Among the speakers: Antoni Ribas, Hiroyoshi Nishikawa, Yosuke Togashi, Andrea Schietinger.
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
- Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, oncolytic viruses, bispecific drugs and cancer vaccines.
- Advance your understanding of topical technological innovation, from single cell analysis tools and NGS approaches to biomarker technologies like mass spectrometry, immunohistochemistry and flow cytometry.
- Examine the latest challenges and technological innovations in preclinical and clinical development with discussions on animal modelling techniques and screening strategies in preclinical development along with the challenges of clinical trial design.
To understand mechanisms that govern innate and adaptive immune responses in infection, neurodevelopment, and inflammatory diseases, this 2-day symposium will convene researchers across the spectrum of immunology to discuss basic immunological questions with the ultimate goal of identifying novel therapeutic strategies for autoimmune and inflammatory diseases, infection, and cancer.
Session topics include immune system homeostasis, long-term consequences of inflammation, neuroimmunology, immunological memory, and systems immunology.
The health and safety of AACR Annual Meeting attendees, as well as the patients and communities they serve, remain the AACR’s highest priorities. Therefore, the AACR will be requiring proof of COVID-19 vaccination for all attendees.
Online registration for the AACR Annual Meeting 2022 will open in October 2021. At that time, a complete list of registration options and rates—as well as details on the vaccination verification process—will be posted.
Save the date.
The sessions of this new edition of the International Congress of Micro-immunotherapy will cover both clinical and research topics from the fields of immunology and metabolism.
The focus of the IRCI symposium allows prominent scientists and clinicians to present their recent data in the multidisciplinary area of immunology in cancer and/or infectious diseases. As in our prior 1st IRCI symposium in 2017, our goal is to keep the number of participants limited thereby driving increased discussion between leaders in the field and attendees, thus strengthening as well as defining immunological research and curative therapies in the near future.
The IRCI meeting is organized by researchers from two leading centers in Lyon, the CIRI and CRCL. The first edition gathered more than 340 people from all around the world. This 2022 edition will highlight the recent discoveries in innate and adaptive immunity, immuno-metabolism; immunotherapy and (epi)genetics.
The Symposium will bring together about 15 accomplished faculty mentors who are excited to share their discoveries and research career experience in cancer immunology with approximately 45 promising young scientists (post-docs and starting PIs).
Participation in the symposium will provide an opportunity to develop strong ties with senior faculty mentors and learn about the different paths to success in cancer immunology research. Participants will learn how excellent science can be advanced by formulating questions, designing and executing studies to address these questions, hiring, mentoring, collaborating, leadership, raising funds, and publishing. Sessions will cover these and other key areas for a successful research career, and include lectures, small discussion/working groups with faculty mentors on specific topics, and review sessions to integrate lessons learned. Participants will also work on updating their research statement to support their next stage of career development.
Applicants are selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. The deadline to apply is Monday, December 20, 2021.
ESMO Congress 2022 will again present the very latest advances in the treatment of cancer and offer an excellent educational programme, with a wealth of opportunities for exchange of ideas among delegates.
We're pleased to announce the 2022 Summit4CI will be held in-person in Montréal, Québec. We hope you'll join us November 19-21, 2022, at the Fairmont The Queen Elizabeth Hotel. Mark your calendar!